Catalent

Yahoo Finance • 3 months ago

Are Investors Undervaluing Catalent, Inc. (NYSE:CTLT) By 24%?

Key Insights Catalent's estimated fair value is US$76.85 based on 2 Stage Free Cash Flow to Equity Catalent is estimated to be 24% undervalued based on current share price of US$58.23 The US$63.43 analyst price target for CTLT is 17% less... Full story

Yahoo Finance • 7 months ago

13 Hot Stocks to Invest in According to Wall Street Analysts

In this piece, we will take a look at the 13 hot stocks to invest in according to Wall Street analysts. If you want to skip our overview of the stock market and the latest news, then you can skip ahead to the 5 Hot Stocks to Invest in Acco... Full story

Yahoo Finance • 9 months ago

Novo Nordisk to acquire three fill-finish sites from Novo Holdings A/S in connection with the Catalent, Inc. transaction

Novo Nordisk A/S Bagsværd, Denmark, 5 February 2024 – Novo Nordisk today announced that the company has agreed to acquire three fill-finish sites from Novo Holdings A/S (Novo Holdings) in connection with a transaction where Novo Holdings... Full story

Yahoo Finance • 12 months ago

Sotera Health Appoints Karen Flynn to Board of Directors

CLEVELAND, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announc... Full story

Yahoo Finance • last year

Weight-loss drugs fuel boom for firms that fill syringes

By Maggie Fick LONDON (Reuters) - Contract drug manufacturers seeking to tap into the booming market for weight-loss drugs are investing billions of dollars to expand or build factories that fill the injection pens used to administer trea... Full story

Yahoo Finance • last year

FOCUS-Weight-loss drugs fuel boom for firms that fill syringes

* Demand soars for self-injection weight-loss drugs * Obesity market could be worth $100 bln within a decade-analysts * Contract drugmakers race to expand capacity to fill syringes By Maggie Fick LONDON, Oct 9 (Reuters) - Contract d... Full story

Yahoo Finance • last year

CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Catalent, Inc. (NYSE: CTLT) on behalf of long-term stockholders foll... Full story

Yahoo Finance • last year

CONTINUED INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Catalent, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CTLT

NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, continues investigating whether certain directors and officers of Catalent, I... Full story

Yahoo Finance • last year

Catalent Receives NYSE Notice Regarding Late Form 10-K Filing

SOMERSET, N.J., September 15, 2023--(BUSINESS WIRE)--Catalent, Inc. ("Catalent" or the "Company") (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that, on Septemb... Full story

Yahoo Finance • last year

Lifshitz Law PLLC Announces Investigations of Alphabet Inc. (NASDAQ: GOOG), Norfolk Southern Corporation (NYSE: NSC), Dutch Bros, Inc. (NYSE: BROS), and Catalent, Inc. (NYSE: CTLT)

NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) -- Alphabet Inc. (NASDAQ: GOOG) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties. Specifically, the investigation relates t... Full story

Yahoo Finance • last year

Is Catalent (CTLT) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap

Value-focused investors are always on the hunt for stocks that are priced below their intrinsic value. One such stock that merits attention is Catalent Inc (NYSE:CTLT). The stock, which is currently priced at $51.4, recorded a gain of 2.39... Full story

Yahoo Finance • last year

Catalent Stock Soars on Agreement With Activist Investor Elliott Management

Battered drug manufacturer agrees to add directors and engage in a strategic review. Wall Street takes a wait-and-see-attitude. Continue reading... Full story

Yahoo Finance • last year

Q4 2023 Catalent Inc Earnings Call

Participants Alessandro Maselli; President, CEO & Director; Catalent, Inc. John Greisch Matti M. Masanovich; Senior VP & CFO; Catalent, Inc. Paul Surdez; VP of IR; Catalent, Inc. David Howard Windley; MD & Equity Analyst; Jefferies LL... Full story

Yahoo Finance • last year

These Stocks Moved the Most Today: Coinbase, AT&T, E.l.f. Beauty, 3M, Big Lots, Best Buy, NIO, and More

Coinbase stock surged after a favorable court ruling for cryptos, AT&T and Verizon stocks were upgraded, E.l.f. Beauty said it is buying skincare brand Naturium, 3M agreed to pay a $6 billion earplugs settlement, and Best Buy's earnings an... Full story

Yahoo Finance • last year

US STOCKS-S&P 500 ends sharply higher, jobs data fuels interest rate optimism

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * Alphabet rises on fresh AI partnerships * PDD jumps after second-quarter revenue beat * Catalent gains on settlement with... Full story

Yahoo Finance • last year

China's Response To Shield Economy From Real Estate Storm, Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle, Google Collaborates With Nvidia In AI Expansion: Today's Top Stories

Bloomberg China Takes Drastic Measures To Shield Economy From Real Estate Storm China is pulling out all the stops in response to the brewing storm within its real estate sector, aiming to prevent the cascading impact from reaching other... Full story

Yahoo Finance • last year

Catalent Stock Rises on Solid Outlook and Deal With Elliot

The drug manufacturer expects $4.3 billion to $4.5 billion in fiscal 2024 revenue. Analysts has been forecasting $4.2 billion. Continue reading... Full story

Yahoo Finance • last year

Unmasking the Potential Value Trap: A Comprehensive Analysis of Catalent Inc

Value-focused investors are always on the hunt for stocks that are priced below their intrinsic value. One such stock that merits attention is Catalent Inc (NYSE:CTLT). The stock, which is currently priced at $43.86, recorded a loss of 1.6... Full story

Yahoo Finance • last year

Catalent (CTLT) Rebounded from Low Post-COVID Valuations

Mairs & Power, an investment advisor, released “Mairs & Power Small Cap Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund was up 0.83% compared to a 2.57% return for the S&P... Full story

Yahoo Finance • last year

Catalent Regains Compliance with NYSE Continued Listing Standards

SOMERSET, N.J., June 13, 2023--(BUSINESS WIRE)--Catalent, Inc. ("Catalent" or the "Company") (NYSE: CTLT) announced today that the Company has received written notification ("Notice") from the New York Stock Exchange ("NYSE") that it has o... Full story